Ulrik Niels Lassen
Clinical Professor
- 2024
- Published
Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways
Skadborg, S. K., Maarup, S., Draghi, A., Borch, A., Hendriksen, S., Mundt Madsen, Filip Oskar, Pedersen, Vilde, Mann, Matthias, Christensen, I. J., Skjøth, Jane, Yde, C. W., Kristensen, Bjarne Winther, Skovgaard Poulsen, H., Hasselbalch, B., Svane, Inge Marie, Lassen, Ulrik Niels & Hadrup, S. R., 2024, In: Cancer Immunology Research. 12, 9, p. 1202–1220 19 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
Characteristics of de novo cancer in liver transplant recipients
Riis, T. H., Møller, D. L., Høgh, J., Knudsen, A. D., Rostved, A. A., Akdag, D., Kirkby, N., Lassen, Ulrik Niels, Rasmussen, A., Hillingsø, Jens Georg & Pommergaard, Hans-Christian L, 2023, In: APMIS. 131, 4, p. 135-141 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Gazzah, A., Lassen, U., Stein, A., Wen, P. Y., Dietrich, S., de Jonge, M. J. A., Blay, J-Y., Italiano, A., Yonemori, K., Cho, D. C., de Vos, F. Y. F. L., Moreau, P., Fernandez, E. E., Schellens, J. H. M., Zielinski, C. C., Redhu, S., Boran, A. & 3 others, , 2023, In: Nature Medicine. 29, 5, p. 1103-1112 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017
Thomsen, M. K., Løppenthin, K. B., Bidstrup, P. E., Andersen, E. W., Dalton, Susanne Oksbjerg, Petersen, L. N., Pappot, Helle, Mortensen, C. E., Christensen, Mikkel Bring, Frølich, Anne, Lassen, Ulrik Niels & Johansen, Christoffer, 2023, In: Acta Oncologica. 62, 12, p. 1653-1660 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
Kummar, S., Shen, L., Hong, D. S., McDermott, R., Keedy, V. L., Casanova, M., Demetri, G. D., Dowlati, A., Melcón, S. G., Lassen, U. N., Leyvraz, S., Liu, T., Moreno, V., Patel, J., Patil, T., Mallick, A. B., Sousa, N., Tahara, M., Ziegler, D. S., Norenberg, R. & 4 others, , 2023, In: Cancer. 129, 23, p. 3772-3782 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
Borch, A., Bjerregaard, A. M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, Inge Marie, Nielsen, Finn Cilius, Funt, S. A., Lassen, Ulrik Niels & Hadrup, S. R., 2023, In: Frontiers in Genetics. 14, 13 p., 1058605.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
New pathogenic germline variants identified in mesothelioma
Belcaid, L., Bertelsen, B., Wadt, Karin Anna Wallentin, Tuxen, I., Spanggaard, I., Højgaard, M., Sørensen, Jens Benn, Ravn, J., Lassen, Ulrik Niels, Nielsen, Finn Cilius, Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, 8 p., 107172.Research output: Contribution to journal › Review › Research › peer-review
- Published
Precision cancer medicine: Concepts, current practice, and future developments
Edsjö, A., Holmquist, L., Geoerger, B., Nowak, F., Gomon, G., Alix-Panabières, C., Ploeger, C., Lassen, Ulrik Niels, Le Tourneau, C., Lehtiö, J., Ott, P. A., von Deimling, A., Fröhling, S., Voest, E., Klauschen, F., Dienstmann, R., Alshibany, A., Siu, L. L. & Stenzinger, A., 2023, In: Journal of Internal Medicine. 294, 4, p. 455-481 27 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, Britt Elmedal, Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, Julie, Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B. & Lassen, Ulrik Niels, 2023, In: BMC Cancer. 23, 1, 12 p., 182.Research output: Contribution to journal › Journal article › Research › peer-review
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis
Lassen, Ulrik Niels, Bokemeyer, C., Garcia-Foncillas, J., Italiano, A., Vassal, G., Paracha, N., Marian, M., Chen, Y., Linsell, L. & Abrams, K., 2023, In: JCO Precision Oncology. 7, 13 p., e2200651.Research output: Contribution to journal › Review › Research › peer-review
ID: 4952653
Most downloads
-
490
downloads
Clinical trial allocation in multinational pharmaceutical companies: a qualitative study on influential factors
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
233
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
188
downloads
Hallmarks of glioblastoma: a systematic review
Research output: Contribution to journal › Review › Research › peer-review
Published